Authors
Loading...
Randomized trial examines distinct impacts of PI3K inhibitors in solid tumors, suggesting tailored treatments for PTEN-negative patients.
Edgar et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: